American International Group, Inc. Neu Base Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.63 - $7.34 $45,309 - $71,829	-9,786 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$6.92 - $12.36 $179 - $321	26 Added 0.27%	9,786 $72,000
Q4 2020 Feb 12, 2021	SELL	$6.92 - $9.25 $1,937 - $2,590	-280 Reduced 2.79%	9,760 $68,000
Q3 2020 Nov 04, 2020	SELL	$7.25 - $9.71 $3,762 - $5,039	-519 Reduced 4.92%	10,040 $76,000
Q2 2020 Aug 12, 2020	BUY	$6.69 - $11.51 $70,639 - $121,534	10,559 New	10,559 $93,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.